Investing
President Donald Trump affirmed on Wednesday that the U.S. would ‘always be there for NATO,’ while accusing the alliance of not sharing the same...
Connect with us
Hi, what are you looking for?
Smart Investment Steps
- Investing
Trump signals long road ahead in Venezuela in his boldest interventionist move yet
Hillary Clinton expected to defy Epstein probe subpoena, risking criminal charges
Rand Paul says GOP colleagues ‘don’t give a s‑‑- about these people in the boats’: They ‘say they’re pro-life’
South Korean prosecutor seeks death penalty for ex-President Yoon over martial law declaration: ‘Self-coup’
Venezuela releases multiple American citizens from prison following military operation
- Stock
- Editor’s Pick
Stock
Warner Bros. Discovery on Wednesday rejected Paramount Skydance’s amended takeover offer, the latest in a series of rejections in David Ellison’s pursuit of the...
Investing
President Donald Trump is setting the stage for the U.S. to be involved in overseeing Venezuela for a significant period of time, after conducting...
Investing
Former Secretary of State Hillary Clinton was subpoenaed to appear before the House Oversight Committee on Wednesday, but she’s expected to ignore the order,...
Investing
Sen. Rand Paul, R-Ky., accused his ‘pro-life’ Republican colleagues of not caring about the people killed in boat strikes near Venezuela who the Trump...
Investing
A South Korean court heard arguments Tuesday seeking the death penalty for former President Yoon Suk Yeol, as prosecutors accused the ousted leader of...
Investing
A House GOP lawmaker is working to find more information after learning one of her constituents was possibly detained by Venezuela’s government. Rep. Nicole...
Investing
President Donald Trump is again amplifying his push for the U.S. to acquire Greenland, reinvigorating his repeated comments earlier in his political career that...
Editor's Pick
TORONTO, ON / ACCESS Newswire / January 7, 2026 / NextSource Materials Inc. (TSX:NEXT,OTC:NSRCF) (‘NextSource’ or the ‘Company’) is pleased to announce that the...
Editor's Pick
Solvonis Therapeutics plc (LSE: SVNS), an emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (‘CNS’) disorders, announces that it has received...
Editor's Pick
